citizenportal.ai
FDA presentation: analytical-data discrepancies caused an ANDA to fail bioequivalence analysis
In Case 1 the presenter said discrepancies between analytical raw data and SAS datasets changed concentration values; using the correct concentrations caused the study to fail bioequivalence criteria, underscoring CRO quality-control needs.